This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, A. S. G.
Right arrow Articles by Wong, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, A. S. G.
Right arrow Articles by Wong, S.-Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2001, p. 2157-2159, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2157-2159.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates

Ann S. G. Lee,1,2,* Audrey S. M. Teo,3 and Sin-Yew Wong3

Department of Clinical Research, Singapore General Hospital, Singapore 169608,1 Division of Medical Sciences, National Cancer Centre, Singapore 169610,2 and Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433,3 Singapore

Received 11 December 2000/Returned for modification 13 February 2001/Accepted 26 April 2001


    ABSTRACT
Top
Abstract
Text
References

Novel mutations in NADH dehydrogenase (ndh) were detected in 8 of 84 (9.5%) isoniazid (INH)-resistant isolates (T110A [n = 1], R268H [n = 7]), but not in 22 INH-susceptible isolates of Mycobacterium tuberculosis. Significantly, all eight isolates with mutations at ndh did not have mutations at katG, kasA, or the promoter regions of inhA or ahpC, except for one isolate. Mutations in ndh appear to be an additional molecular mechanism for isoniazid resistance in M. tuberculosis.


    TEXT
Top
Abstract
Text
References

Resistance to isoniazid (INH) in Mycobacterium tuberculosis is attributed to mutations in several genes. The katG gene, which encodes catalase-peroxidase, is the gene most commonly altered, with the majority of mutations occurring at codon 315 (1, 9, 13). Mutations in the promoter regions of inhA (9, 13, 17) and oxyR-ahpC genes (2, 15) have been identified in INH-resistant strains but not INH-susceptible strains. Four independent mutations were also reported to be found in the kasA gene of INH-resistant M. tuberculosis strains (7), but recent work showed that three of these four mutations are found in INH-susceptible isolates as well (3, 10). The common arginine-to-leucine substitution in codon 463 of the katG gene is now thought to be a polymorphism, as this amino acid substitution is detectable in both susceptible and resistant strains (4, 9).

Determination of drug resistance in M. tuberculosis routinely takes 3 to 8 weeks as the clinical samples need to be cultured. In order to hasten this process, targeted molecular approaches have been done in Europe and the United States (9, 17). In Spain, molecular analysis of part of the coding sequence of katG and the promoter regions of inhA and ahpC was shown to be effective in detecting resistance in 87% of INH-resistant isolates (17). A previous study used a similar strategy, targeting four genes: katG, kasA, and the promoter regions of inhA and ahpC (3). Results showed, however, that 36% of the Singaporean isolates had no detectable alterations at these genes, suggesting that other molecular mechanisms may be in play (3).

Recently, a new mechanism for INH resistance in Mycobacterium smegmatis has been identified (8). Mutations in the ndh gene, encoding an NADH dehydrogenase, caused defects in the enzyme activity that resulted in an increased NADH/NAD+ ratio and coresistance to isoniazid and ethionamide. This mechanism has not been previously reported for M. tuberculosis. In the present study, 84 INH-resistant and 22 INH-susceptible M. tuberculosis isolates have been screened for mutations in the ndh gene in order to assess if NADH dehydrogenase defects contribute to isoniazid resistance in M. tuberculosis isolates in Singapore.

Consecutive isoniazid-resistant M. tuberculosis isolates were collected from the Central Tuberculosis Laboratory from August 1994 to December 1996. Drug susceptibility testing was done using the BACTEC 460 radiometric method (Becton Dickinson, Towson, Md.), and the isoniazid concentration was 0.1 µg/ml. Eighty-four M. tuberculosis isolates monoresistant to INH, none of which were multidrug resistant, and 22 INH-susceptible isolates were analyzed.

Amplification of the codon 315 region of the katG gene, promoter regions of the inhA and ahpC genes, and the entire kasA gene was performed as previously described (3). The entire ndh gene was studied by amplifying five overlapping fragments using the PCR primers shown in Table 1. The PCR products were purified (QIAquick PCR purification kit or QIAquick gel extraction kit; QIAGEN) and directly sequenced using the BigDye Terminators sequencing kit and the ABI PRISM 377 automated sequencer (PE Biosystems, Branchburg, N.J.). Isolates with mutations were reamplified and resequenced in order to confirm the results.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Oligonucleotide primer sequences for the amplification of the entire ndh genea

Mutations in the ndh gene were detected in 8 (9.5%) of the 84 INH-resistant isolates (T110A [n = 1] and R268H [n = 7]). The T110A mutation was present in the second PCR fragment, and the R268H mutation was present in the third. Neither of these mutations was detected in any of the 22 INH-susceptible isolates. Seven of the eight isolates with these mutations did not have any other detectable molecular alterations at other known target genes for INH resistance.

The 84 INH-resistant isolates have previously been screened also for mutations or deletions at the katG gene, mutations in the promoter regions of the inhA and ahpC-oxyR genes, and mutations in the kasA gene (3). Table 2 shows the results of the genotypic analysis for these genes as well as for the ndh gene. Of the eight isolates with mutations in the ndh gene, seven did not have any mutations at any of the other targeted regions screened, and one isolate (R268H in ndh) also had a mutation in the ahpC gene at T51.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Genetic screening of 84 INH-resistant M. tuberculosis isolates from Singapore

DNA fingerprinting of the eight isolates with mutations in the ndh gene was done using IS6110 restriction fragment length polymorphism typing (18) and the recently described minisatellite-based typing (6, 16). The isolate with the T110A mutation had a 16-band IS6110 fingerprint, while the seven isolates with the R268H alteration had single 1.4-kb band IS6110 fingerprint. Minisatellite-based typing showed that these eight isolates were unrelated except for two isolates with the R268H alteration.

The mutations detected in the present study occur at positions which differ from those of previously published mutations of the ndh gene in M. smegmatis (Fig. 1) (8). The amino acid positions 110 and 268 are conserved in mycobacteria but not in Escherichia coli and Synechocystis spp. (8). These amino acids are not within the NAD and flavin adenine dinucleotide binding domains.


View larger version (47K):
[in this window]
[in a new window]
  		FIG. 1.   Protein sequence alignment of the Ndh enzyme of M. smegmatis and M. tuberculosis. The amino acids that have been previously reported to be mutated in M. smegmatis are in boldface print, while those found to be mutated in M. tuberculosis in the present study are underlined.

The mechanism for INH resistance in M. tuberculosis isolates with ndh mutations is likely an increase in the NADH/NAD+ ratios in the M. tuberculosis cells as was shown for M. smegmatis (8). These higher levels of NADH might competitively inhibit the binding of the INH-NAD adduct to the active site of the InhA enzyme (12, 14). Alternatively, since NADH is a substrate for the peroxidases AhpCF and KatG (5, 11), increased concentrations of NADH may competitively inhibit the peroxidation of INH by KatG (8). Miesel et al. have proposed that an increase in the NADH concentration prevents the action of INH and ethionamide which act in conjunction to confer high-level resistance (8).

Seven of the eight (87.5%) isolates had the same mutation (R268H) in the ndh gene. Rapid screening of mutations at this position may be possible for isolates from other geographical regions such as the United States and Europe, in order to determine the prevalence of this mutation in these areas and possibly add to the targeted approach for the detection of INH resistance.

In contrast, in Singapore a targeted approach for the identification of INH resistance with five genes detected genotypic changes in only 63% of the M. tuberculosis isolates. Further work is needed to fully elucidate alternative molecular mechanisms for INH resistance in M. tuberculosis.

In conclusion, this is the first report of the detection of novel mutations in the ndh gene in INH-resistant M. tuberculosis isolates. The data suggest an additional molecular mechanism for INH resistance.


    ACKNOWLEDGMENTS

We acknowledge the Central Tuberculosis Laboratory, Department of Pathology, Singapore General Hospital, for providing isolates. We thank Lynn L. H. Tang and Irene H. K. Lim for excellent technical assistance and are grateful to the Clinical Research Unit, Tan Tock Seng Hospital, for administrative support.

This work was supported by a grant from the National Medical Research Council of Singapore (grant NMRC/329/1999).


    FOOTNOTES

* Corresponding author. Mailing address: Division of Medical Sciences, National Cancer Centre, Republic of Singapore 169610. Phone: 65-436 8313. Fax: 65-372 0161. E-mail: dmslsg{at}nccs.com.sg.


    REFERENCES
Top
Abstract
Text
References

1. Heym, B., P. M. Alzari, N. Honore, and S. T. Cole. 1995. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:235-245[Medline].
2. Kelley, C. L., D. A. Rouse, and S. L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:2057-2058[Abstract].
3. Lee, A. S. G., I. H. K. Lim, L. L. H. Tang, A. Telenti, and S. Y. Wong. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43:2087-2089[Abstract/Free Full Text].
4. Lee, A. S. G., L. L. H. Tang, I. H. K. Lim, M. L. Ling, L. Tay, and S. Y. Wong. 1997. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. J. Infect. Dis. 176:1125-1126[Medline].
5. Marcinkeviciene, J. A., R. S. Magliozzo, and J. S. Blanchard. 1995. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J. Biol. Chem. 270:22290-22295[Abstract/Free Full Text].
6. Mazars, E., S. Lesjean, A.-L. Banuls, M. Gilbert, V. Vincent, B. Gicquel, M. Tibayrenc, C. Locht, and P. Supply. 2001. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc. Natl. Acad. Sci. USA 98:1901-1906[Abstract/Free Full Text].
7. Mdluli, K., R. A. Slayden, Y. Q. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry, III. 1998. Inhibition of a Mycobacterium tuberculosis beta -ketoacyl ACP synthase by isoniazid. Science 280:1607-1610[Abstract/Free Full Text].
8. Miesel, L., T. R. Weisbrod, J. A. Marcinkeviciene, R. Bittman, and W. R. Jacobs. 1998. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J. Bacteriol. 180:2459-2467[Abstract/Free Full Text].
9. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. A. van Embden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202[Medline].
10. Piatek, A. S., A. Telenti, M. R. Murray, H. El-Hajj, W. R. Jacobs, F. R. Kramer, and D. Alland. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44:103-110[Abstract/Free Full Text].
11. Poole, L. B., and H. R. Ellis. 1996. Flavin-dependent alkyl hydroperoxide reductase from Salmonella typhimurium. 1. Purification and enzymatic activities of overexpressed AhpF and AhpC proteins. Biochemistry 35:56-64[CrossRef][Medline].
12. Quemard, A., J. C. Sacchettini, A. Dessen, C. Vilcheze, R. Bittman, W. R. Jacobs, Jr., and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241[CrossRef][Medline].
13. Rouse, D. A., Z. M. Li, G. H. Bai, and S. L. Morris. 1995. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:2472-2477[Abstract].
14. Rozwarski, D. A., G. A. Grant, D. H. R. Barton, W. R. Jacobs, Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102[Abstract/Free Full Text].
15. Sreevatsan, S., X. Pan, Y. Zhang, V. Deretic, and J. M. Musser. 1997. Analysis of oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41:600-606[Abstract].
16. Supply, P., E. Mazars, S. Lesjean, V. Vincent, B. Gicquel, and C. Locht. 2000. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol. Microbiol. 36:762-771[CrossRef][Medline].
17. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723[Abstract].
18. Van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409[Abstract/Free Full Text].

Antimicrobial Agents and Chemotherapy, July 2001, p. 2157-2159, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2157-2159.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ho, Y. M., Sun, Y.-J., Wong, S.-Y., Lee, A. S. G. (2009). Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates. Antimicrob. Agents Chemother. 53: 4010-4012 [Abstract] [Full Text]  
  • Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., Victor, T. C. (2009). A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance. Antimicrob. Agents Chemother. 53: 3181-3189 [Full Text]  
  • O'Sullivan, D. M., McHugh, T. D., Gillespie, S. H. (2008). The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function. J Antimicrob Chemother 62: 709-712 [Abstract] [Full Text]  
  • Karakousis, P. C., Williams, E. P., Bishai, W. R. (2008). Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. J Antimicrob Chemother 61: 323-331 [Abstract] [Full Text]  
  • Siddiqi, S., Takhar, P., Baldeviano, C., Glover, W., Zhang, Y. (2007). Isoniazid Induces Its Own Resistance in Nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 2100-2104 [Abstract] [Full Text]  
  • Sekiguchi, J.-i., Miyoshi-Akiyama, T., Augustynowicz-Kopec, E., Zwolska, Z., Kirikae, F., Toyota, E., Kobayashi, I., Morita, K., Kudo, K., Kato, S., Kuratsuji, T., Mori, T., Kirikae, T. (2007). Detection of Multidrug Resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 179-192 [Abstract] [Full Text]  
  • Guo, H., Seet, Q., Denkin, S., Parsons, L., Zhang, Y. (2006). Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.. J Med Microbiol 55: 1527-1531 [Abstract] [Full Text]  
  • Hazbon, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de Leon, A., Alland, D. (2006). Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis.. Antimicrob. Agents Chemother. 50: 2640-2649 [Abstract] [Full Text]  
  • Miotto, P., Piana, F., Penati, V., Canducci, F., Migliori, G. B., Cirillo, D. M. (2006). Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in Italy.. J. Clin. Microbiol. 44: 2485-2491 [Abstract] [Full Text]  
  • Aragon, L. M., Navarro, F., Heiser, V., Garrigo, M., Espanol, M., Coll, P. (2006). Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J Antimicrob Chemother 57: 825-831 [Abstract] [Full Text]  
  • Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., Rubin, H. (2006). Steady-state Kinetics and Inhibitory Action of Antitubercular Phenothiazines on Mycobacterium tuberculosis Type-II NADH-Menaquinone Oxidoreductase (NDH-2). J. Biol. Chem. 281: 11456-11463 [Abstract] [Full Text]  
  • Sholto-Douglas-Vernon, C., Sandy, J., Victor, T. C, Sim, E., Helden, P. D. (2005). Mutational and expression analysis of tbnat and its response to isoniazid. J Med Microbiol 54: 1189-1197 [Abstract] [Full Text]  
  • Zhang, M., Yue, J., Yang, Y.-p., Zhang, H.-m., Lei, J.-q., Jin, R.-l., Zhang, X.-l., Wang, H.-h. (2005). Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China. J. Clin. Microbiol. 43: 5477-5482 [Abstract] [Full Text]  
  • Hillemann, D., Weizenegger, M., Kubica, T., Richter, E., Niemann, S. (2005). Use of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. J. Clin. Microbiol. 43: 3699-3703 [Abstract] [Full Text]  
  • Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Wong, S. Y. (2005). High Frequency of Mutations in the rpoB Gene in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Singapore. J. Clin. Microbiol. 43: 2026-2027 [Full Text]  
  • Hillemann, D., Kubica, T., Rusch-Gerdes, S., Niemann, S. (2005). Disequilibrium in Distribution of Resistance Mutations among Mycobacterium tuberculosis Beijing and Non-Beijing Strains Isolated from Patients in Germany. Antimicrob. Agents Chemother. 49: 1229-1231 [Abstract] [Full Text]  
  • Vilcheze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbon, M. H., Wang, F., Alland, D., Sacchettini, J. C., Jacobs, W. R. Jr. (2005). Altered NADH/NAD+ Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria. Antimicrob. Agents Chemother. 49: 708-720 [Abstract] [Full Text]  
  • Lin, S.-Y. G., Probert, W., Lo, M., Desmond, E. (2004). Rapid Detection of Isoniazid and Rifampin Resistance Mutations in Mycobacterium tuberculosis Complex from Cultures or Smear-Positive Sputa by Use of Molecular Beacons. J. Clin. Microbiol. 42: 4204-4208 [Abstract] [Full Text]  
  • Leung, E. T.-Y., Kam, K.-M., Chiu, A., Ho, P.-L., Seto, W.-H., Yuen, K.-Y., Yam, W.-C. (2003). Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J Med Microbiol 52: 999-1003 [Abstract] [Full Text]  
  • Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. M., Telles, M. A., Kritski, A., Morlock, G. P., Cooksey, R. C., Zaha, A., Rossetti, M. L. R. (2003). Mutations in katG, inhA, and ahpC Genes of Brazilian Isoniazid-Resistant Isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41: 4471-4474 [Abstract] [Full Text]  
  • Bakonyte, D., Baranauskaite, A., Cicenaite, J., Sosnovskaja, A., Stakenas, P. (2003). Molecular Characterization of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates in Lithuania. Antimicrob. Agents Chemother. 47: 2009-2011 [Abstract] [Full Text]  
  • Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., Graviss, E. A. (2003). Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47: 1241-1250 [Abstract] [Full Text]  
  • Tracevska, T., Jansone, I., Broka, L., Marga, O., Baumanis, V. (2002). Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia. J. Clin. Microbiol. 40: 3789-3792 [Abstract] [Full Text]  
  • Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D., Amaral, L. (2002). Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46: 2804-2810 [Abstract] [Full Text]  
  • Lee, A. S. G., Tang, L. L. H., Lim, I. H. K., Bellamy, R., Wong, S.-Y. (2002). Discrimination of Single-Copy IS6110 DNA Fingerprints of Mycobacterium tuberculosis Isolates by High-Resolution Minisatellite-Based Typing. J. Clin. Microbiol. 40: 657-659 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, A. S. G.
Right arrow Articles by Wong, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, A. S. G.
Right arrow Articles by Wong, S.-Y.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»